Dr Jan Ramaekers (J.G.)

Lege, K. S., Mallaroni, P., Mortaheb, S., Mason, N. L., Theunissen, E. L., Tse, D. H. Y., Toennes, S. W., Demertzi, A., & Ramaekers, J. G. (2026). Cannabis Perturbs Dynamic Brain States. Biological Psychiatry, 100(2), 219-229. https://doi.org/10.1016/j.biopsych.2025.10.015

Bhavaraju, K. P., Mason, N. L., Mallaroni, P., Heinke, D., Toennes, S. W., Ramaekers, J. G., & Amico, E. (2026). Unmixing the Psychedelic Connectome: Brain Network Traits of Psilocybin. Network neuroscience. Advance online publication. https://doi.org/10.1162/NETN.a.594

Ramaekers, JG., Bade, R., & Hall, W. (2026). How can we facilitate research on the risks and potential benefits of novel psychoactive substances? EClinicalMedicine, 97, Article 104030. https://doi.org/10.1016/j.eclinm.2026.104030

Cubala, W. J., Bajbouj, M., Bauer, M., Baune, B. T., Cardoner, N., Devlin, F., Doolin, K., Duenas Herrero, R. M., Elices, M., Feeney, A., Galuszko-Wegielnik, M., Jakuszkowiak-Wojten, K., Janu, L., Kelly, J. R., Ledden, K., Maclsaac, R., Madero, S., Mcinerney, S. J., Montejo, A. L., ... Thase, M. E. (2026). GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry, 83(6), 561-569. https://doi.org/10.1001/jamapsychiatry.2026.0096

Madrid-Gambin, F., Mallaroni, P., Haro, N., Pozo, O. J., Mason, N. L., Reckweg, J. T., Kloft-Heller, L., van Oorsouw, K., Toennes, S. W., & Ramaekers, J. G. (2026). Brain-body integromics of the ayahuasca experience. Biomedicine & Pharmacotherapy, 199, Article 119391. https://doi.org/10.1016/j.biopha.2026.119391

Mallaroni, P., Singleton, S. P., Mason, N. L., Satterthwaite, T. D., & Ramaekers, J. G. (2026). Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin. Molecular Psychiatry, 31(6), 3295-3307. https://doi.org/10.1038/s41380-026-03447-0

Uthaug, M. V., Lancelotta, R., Szabo, A., Davis, A. K., Riba, J., & Ramaekers, J. G. (2026). Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment (vol 237, pg 773, 2020). Psychopharmacology. Advance online publication. https://doi.org/10.1007/s00213-026-07086-9

Griesfeller, A.-F., Kooman, L., Kloft-Heller, L., Kangaslampi, S., Ramaekers, J. G., & Otgaar, H. (2026). Evaluating the evidence for repressed memory recovery in psychedelic contexts. Psychopharmacology. Advance online publication. https://doi.org/10.1007/s00213-026-07076-x

Ramaekers, J. G., Kuypers, K. P. C., & Vollenweider, F. X. (2026). Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use. Molecular Psychiatry. Advance online publication. https://doi.org/10.1038/s41380-026-03602-7

Girn, M., Doss, M. K., Roseman, L., Preller, K. H., Palhano-Fontes, F., Pasquini, L., Barrett, F. S., Mallaroni, P., Mason, N. L., Timmermann, C., McCulloch, D. E., Fisher, P. M., Winston, B. S., Moujaes, F., Muller, F., Liechti, M. E., Vollenweider, F. X., Ramaekers, J. G., Kuypers, K., ... Bzdok, D. (2026). An international mega-analysis of psychedelic drug effects on brain circuit function. Nature Medicine, 32(4), 1543-1554. https://doi.org/10.1038/s41591-026-04287-9